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Less invasive causal treatment of ejaculatory duct
obstruction by balloon dilation: a case report, literature
reviewandsuggestionofaCT-orMRI-guidedintervention
Minimal-invasive Behandlungsmöglichkeiten des Verschlusses des
Ductus ejaculatorius durch Ballondilatation: ein Fallbericht,
Literaturübersicht und ein Vorschlag für eine CT- oder MRT-gesteuerte
Intervention
Abstract
Uni- or bilateral ejaculatory duct obstruction (EDO) is a rare but correct-
able cause of infertility, chronic pelvic pain and postejaculatory pain.
Ole Kayser
1
Daniar Osmonov
2
EDO is a congenital or acquired condition, it is the underlying cause of
infertility in approximately 5% of infertile men. If acquired, the etiology Jonas Harde
3
Guido Girolami
1 often remains unresolved, but prostatitis or urethritis with post-inflam-
matory adhesion of the duct walls seems to be a common underlying
pathomechanism. Thilo Wedel
3
Philipp Schäfer
1
Althoughacertainconstellationofphysicochemicalsemenparameters
may lead to correct diagnosis, EDO often resembles a diagnosis by ex-
clusion. Imaging of acquired EDO remains a challenge and the estab- 1 Department of Radiology,
UniversityHospitalSchleswig-
Holstein, Kiel, Germany
lished surgical therapy, transurethral resection of the ejaculatory ducts
(TURED), leads to a low rate of natural conception and a high rate of
complications such as reflux of urine and epididymitis. 2 Department of Urology,
UniversityHospitalSchleswig-
Holstein, Kiel, Germany
We present a case of a male with suspected EDO who underwent a
combined approach to both, semi-invasive diagnosis and therapy by
transrectal puncture of the seminal vesicles and antegrade balloon-
3 Anatomical Institute,
UniversityHospitalSchleswig-
Holstein, Kiel, Germany
dilation of the ejaculatory ducts. Possibilities and pitfalls of this proced-
ure are described and the literature is reviewed.
Furthermore,wesuggestaCT-orMRI-guided,percutaneousintervention
for treatment of ejaculatory duct obstruction by balloon dilation and
demonstrate initial steps of this procedure with a body donor. We call
this new procedure PTED (percutaneous transgluteal ejaculatory
ductoplasty).
Keywords: ejaculatory duct, EDO, ejaculatory duct obstruction, TURED,
resection of the ejaculatory duct, balloon dilation, CT, transgluteal
Zusammenfassung
Ein ein- oder beidseitiger Verschluss des Ductus ejaculatorius (EDO) ist
eine seltene, aber behandelbare Ursache von Infertilität, chronischem
Beckenschmerz und postejaculatorischen Schmerzen.
EDO ist ein angeborener oder erworbener Zustand. Es ist in ca. 5% der
Fälle die zugrundeliegende Ursache für männliche Infertilität. Die Ätio-
logie bleibt in den meisten erworbenen Fällen unklar, jedoch scheint
eine Prostatitis oder Urethritis mit postinflammatorischer Adhäsion der
WändederDuctuliejaculatoriieinhäufigerPathomechanismuszusein.
ObwohleinebestimmteKonstellationvonchemischenParameterndes
Seminalplasmas in Zusammenschau mit dem Spermiogramm zur kor-
rekten Diagnose führen kann, bleibt EDO in den meisten Fällen eine
Ausschlussdiagnose. Die bildgebende Diagnostik von erworbener EDO
isteinungelöstesProblemunddieetabliertechirurgischeTherapie,die
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Case Report OPEN ACCESStransurethrale Resektion des Ductus ejaculatorius (TURED), führt zu
einer geringen natürlichen Empfängnisrate und einer relativ hohen
Komplikationsrate wie z.B. Reflux von Urin und Epididymitis.
Wir präsentieren den Fall eines Mannes mit Verdacht auf EDO, der sich
einer kombinierten Intervention zur semi-invasiven Diagnostik und
Therapie durch transrektale Punktion der Vesiculae seminales und an-
tegrader Ballondilatation des Ductus ejaculatorius unterzog.
Möglichkeiten und Schwierigkeiten dieser Prozedur werden erläutert
und eine Literaturübersicht wird präsentiert.
Desweiteren schlagen wir eine CT- oder MRT-gesteuerte, perkutane In-
tervention zur Behandlung des Verschlusses des Ductus ejaculatorius
vor und demonstrieren initiale Schritte dieser Prozedur an einem Kör-
perspender.WirnennendieseProzedurPTED(percutaneoustransgluteal
ejaculatory ductoplasty).
Schlüsselwörter: Verschluss des Ductus ejaculatorius, transurethrale
Resektion des Ductus ejaculatorius, Ballondilatation, CT, transgluteal
Introduction
Stenosis or obstruction as the underlying cause of mal-
function or disease is a recurring theme in medicine.
Obstruction of the common bile duct, ducts of salivary or
lacrimal glands, fallopian tube and vascular occlusion
are common examples.
Thedistalendsofthevasdeferensmergewiththeoutlets
of the seminal vesicles to form the ejaculatory ducts,
which pass obliquely through the prostate to open on
either side of the verumontanum at the apex of the pro-
state.Ejaculatoryductobstruction(EDO)isanuncommon
but correctable cause of infertility, chronic pelvic pain
and postejaculatory pain [1], [2], [3], [4].
It may lead to psychosocial impairment [5]. EDO is a
congenital or acquired condition, it is described to be the
underlying cause of infertility in approximately 5% of in-
fertilemen.Ifacquired,prostatitisseemstobeacommon
underlying pathomechanism [6], [7].
EDO is a mismatch between the pressure that is exerted
by the smooth muscles of the seminal vesicle wall and
the pelvic muscles on the one hand and the pressure
that is required to transport the viscous seminal fluid
through the ejaculatory duct on the other hand.
In complete and bilateral obstruction, affected men
presentwithatypicalconstellationofsemenparameters
(low volume semen, low fructose-level, low pH, high level
of zink, low level of alpha-Glucosidase, azoospermia or
oligozoospermia).
This typical pattern of physicochemical parameters in
seminal fluid and a relatively fluid, low volume semen is
a logical consequence of the missing constituents origin-
ating from the testis, epididymis and seminal vesicles
[8].
In complete and bilateral obstruction of the ejaculatory
ducts, seminal plasma, if any, is only comprised of the
secretion of the accessory bulbourethral glands (Cowper
glands) and secretion of the prostate.
However, since EDO may be partial on both ducts or only
one of the two ducts may be affected, chemical analysis
of seminal plasma is not specific for EDO.
Imaging of EDO remains a challenge [4], [9], [10], [11].
In short, transrectal ultrasound (TRUS) is presently the
standard imaging modality and serves well to rule-out
müllerianductcystsandothercongenitalanomaliessuch
as absent seminal vesicles. Magnetic resonance tomo-
graphy with an endorectal coil performs equally well.
However, the resolution of both imaging modalities is not
sufficient to observe the status of the ejaculatory ducts
directly.
Although the observation of dilated seminal vesicles was
reported to be another indirect sign leading towards the
diagnosis of EDO, it is not specific.
Thus, functional imaging-based tests are necessary to
demonstrate a partial or complete obstruction of one or
both ejaculatory ducts. In favor of transrectal or transcu-
taneous fluoroscopic vesiculography, in our opinion the
fine-needle vasography [12] is less suited, because the
vas deferens is injured which may lead to scarring and
subsequent obstruction caused by vasography.
Furthermore, transrectal seminal vesicle aspiration with
succeeding sperm-count serves as another diagnostic
criterion for EDO [13]. Recently, manometry was com-
bined with transrectal fluoroscopic vesiculography to
diagnose partial EDO [14].
The standard therapeutic approach to EDO is
transurethral resection of the ejaculatory ducts (TURED).
This procedure includes the resection of the membrane-
like valve at the urethral orifices of the ejaculatory ducts,
which are thought to serve as a barrier against reflux of
urineintotheseminalvesicles.Only20%ofpatientswho
underwent TURED are able to initiate pregnancy of their
partnersbynaturalconceptionandsemenqualityisoften
impaired by reflux of urine into the seminal vesicles. An-
other complication of TURED is recurrent epididymitis
[15], [16], [17].
Thus, in practice, TESE in combination with in-vitro fertil-
isation(IVF)oftenremainstherecommendedtherapyfor
infertility caused by EDO, although it is not a causal
therapy.Furthermore,withIVF,themainpartoftreatment
is transferred to the (originally not affected) partner.
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Kayser et al.: Less invasive causal treatment of ejaculatory duct ...Jarow et al. have demonstrated the feasibililty of trans-
rectal balloon dilation of the ejaculatory ducts [18], [19].
However, there are no reports on this procedure by other
groups.Thus,wewantedtoconfirmtheresultspublished
by Jarow et al.
In addition, we suggest CT- or MRI-guided percutaneous,
transgluteal balloon dilation of the ejaculatory ducts
(PTED) as a new, less-invasive treatment option for EDO.
The idea of this procedure is to establish an antegrade
through-and-through access to the penile urethra by
percutaneous, transischiorectal insertion of a cannula
into the seminal vesicle over which a guidewire and a
steering catheter are inserted into the seminal vesicle.
The guide-wire is then advanced through the ejaculatory
duct into the urethra. Subsequently, a balloon-catheter
could be inserted over the guide-wire for dilation of the
ejaculatory duct in a retrograde, transurethral fashion.
Case description
Approval by the local ethical review board was granted
toperformthepreviouslypublishedtransrectalprocedure
in patients with EDO [19]. One 35-year-old patient with
dryejaculation,normalbloodparameters,hormoneserum
levels within reference range, normal TRUS-findings and
unremarkableMRI-evaluationwhodidnotwanttounder-
go TURED was included for treatment of infertility. He re-
ported to have fathered two childs 7 and 10 years earlier
and reported the onset of decreasing volume of semen
several years ago with no linkage to a particular event.
He described to feel normal orgasmic sensations and
muscle contractions and no pelvic pain. Retrograde
ejaculation was ruled out by analysis of urine sediment.
Informed consent was obtained from the patient and an
insurance for the clinical study was filed.
TRUS-andfluoroscopy-guidedtransrectal
andtransurethralprocedure,performed
on patient
Theprocedurewasperformedsimilaraspublishedprevi-
ously [19].
A 17 French rigid panendoscope (Karl Storz, Tuttlingen,
Germany) was placed into the penile urethra to observe
theorificesoftheejaculatoryductsattheverumontanum.
A PTFE Guidewire was advanced through the working
channelforretrogradeintubationoftheejaculatoryducts.
Under guidance of a 12 Mhz transrectal biplane ultra-
sound probe (B+K Medical, Peabody, MA, USA), a
17 gauge needle was transrectally inserted into the
seminal vesicle through the sterile needle guide of the
rectalultrasound-probe,ascommonlyusedfortransrectal
biopsy of the prostate.
Position was confirmed by aspiration and injection of a
small amount of iodinated contrast agent (Imeron 300,
Bracco,Konstanz,Germany)underfluoroscopicguidance
(Philips Urodiagnost, Hamburg, Germany).
A 0.035 J-Tip PTFE Guidewire (Cordis, Warren, USA) was
inserted through the needle, the coiling of the guidwire
within the seminal vesicle was confirmed by fluoroscopy.
The needle was removed and a 4 french multipurpose-
catheter (Cordis) was advanced into the seminal vesicle
over the guidewire. The guidewire was exchanged for a
0.035 inch Glidewire (Terumo, Somerset, NJ, USA).
The procedure was modified with a 4 french cobra cath-
eter (Cordis) and/or a 0.018 inch hydrophilic, straight-tip
guidewire (Boston Scientific, Natick, NA, USA). The pro-
cedure was repeated for the contralateral vesicle.
The patient received perioperative antibiotics (200 mg
Ciprofloxacin and 0.5 g Metronidazol i.v. during interven-
tion and 0.5 g Metronidazol i.v. 4 h post-intervention as
well as 500 mg Ciprofloxacin tablets once daily and
400 mg metronidazol tablets twice daily for 3 days post-
intervention).
Result
Wedidnotachievetoprobetheorificesoftheejaculatory
ducts in a transurethral, retrograde fashion via the pan-
endoscope, because it was impossible to identify their
urethral orifices on the verumontanum. This is in accord-
ancewithpreviousreports[18].Furthermore,theorifices
may be scarred in patients with EDO and thus inaccess-
ible to a retrograde approach.
Although it was not difficult to place a guidewire within
the seminal vesicles through a needle via a transrectal
access (Figure 1, Figure 2), it was especially difficult to
apply sufficient pressure to insert the angiographic cath-
eterovertheguide-wireintotheseminalvesicle.Instead,
thecathetertendedtocoilwithinthelumenoftherectum.
Although the seminal vesicles were easily detectable by
injection of contrast-agent, it was not possible to reliably
observe contrast-agent within the prostatic urethra by
fluoroscopy. However, the vesicles did not remarkably
enlarge either and there was a visible flow of fluid within
the urethra detected by TRUS, leading to the diagnosis
of partial rather than complete EDO. Alternatively, in ac-
cordance to the concept of a mismatch of required pres-
sureandavailablepressure,alackofavailablepressure,
i.e.neuralormuscularimpairmentofcontractionsduring
orgasm may have been the cause of dry ejaculation in
this particular patient.
Thepatientwasdischargedhomethenextdayandmade
an unremarkable recovery.
CT- guided transgluteal procedure,
performed on body donor
One male body donor (74 years) was obtained from the
anatomical institute. Transports between institutes were
carried out by a funeral parlor.
Thecorpsewasplacedinlateralpositiononamultidetect-
orCT(Somatom64,Siemens,Germany).Afteracquisition
of a spiral-CT for planning, a 20 cm, 20 gauge, Chiba
needle (US Biopsy LLC, Franklin, IN, USA) was transglu-
teally advanced into the seminal vesicle. The path of the
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Kayser et al.: Less invasive causal treatment of ejaculatory duct ...Figure 1: Transrectal injection of contrast-agent into the right seminal vesicle confirms correct location of needle. Fluoroscopy.
Figure2:Subsequenttotransrectalinsertionofaguide-wireintotherightseminalvesicle,itwasdirectedtowardstheinfundibulum
of the seminal vesicle/into the direction of the ejaculatory ducts, but could not be further advanced. Fluoroscopy.
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CT-slices. A 0.035 J-Tip PTFE Guidewire (Cordis, Warren,
USA) was inserted through the needle, the coiling of the
guidwire within the seminal vesicle was confirmed by CT.
The Chiba needle was exchanged for a standard an-
giographic catheter sheath (11 cm) for a 4F catheter
(Cordis, Warren, USA) and the guidewire was removed. A
4F multipurpose-catheter (Cordis) was introduced into
theseminalvesicle,anda0.035inchGlidewire(Terumo,
Somerset, NJ, USA) was used to probe the ejaculatory
duct. 1:10 saline-diluted contrast agent (Imeron 250,
Bracco, Konstanz, Germany) was injected to confirm in-
travesicular position.
Subsequent CT-Scans were used to monitor the position
of the instruments. The procedure was repeated for the
contralateral seminal vesicle.
Result
Needle, guidewire, sheath and catheter could all be
placed into the seminal vesicle as demonstrated by CT-
Imaging(Figure3).Theguidewirecoiledwithinthelumen
of the seminal vesicle and we did not achieve to steer
the guidewire through the ejaculatory duct to achieve a
through-and-through access to the penile urethra.
Therefore, we were not able to proceed to insertion of a
balloon-catheter over the guidewire in a subsequent
retrograde approach.
Figure 3: A 17 mm maximum intensity projection of a CT-Scan
showsaguide-wirecoiledwithinthelumenoftherightseminal
vesicle and an angiographic catheter sheath inserted into the
seminal vesicle.
Discussion
It was previously stated, that a retrograde approach to
insert a guidewire into the seminal vesicles is difficult, if
not impossible due to the tiny and potentially scarred ur-
ethralorificesoftheejaculatoryducts[18].Theopenings
areusuallycoveredbyathinmembranewhichisthought
toserveasavalvetoinhibitrefluxofurine[18].Recently,
it was reported, that retrograde vesiculoscopy with an
ureteroscope is possible [20]. However, the investigators
state that they had to resect the verumonatum to insert
the vesiculoscope.
Likewise,wewerenotabletoidentifyorinsertaguidewire
into the urethral orifices of the ejaculatory ducts in a
transurethral, i.e. retrograde approach.
In contrast to TURED, balloon dilation of the ejaculatory
ducts could also treat proximal obstruction of the ejacu-
latory duct, since it is not necessary to resect prostatic
tissue close to the prostatic capsule, which imposes a
high risk of injury to the periprostatic neurovascular
bundlesandthusariskoferectiledysfunctionandincon-
tinence [18].
Thevalve-likemembraneattheorificesoftheejaculatory
ducts can be conserved by balloon dilation [19], typical
complications of TURED such as urinary reflux and thus
epididymitis,lowsemenqualityandlowrateofpregnancy
[17] may be avoided.
Thus, balloon dilation is a promising alternative for the
causal treatment of EDO.
In a previous experiment, we were able to advance a hy-
drophilic terumo glidewire (0.035 inch) through the
ejaculatoryductsintotheprostaticurethrainaprostatec-
tomy-specimenunderfluoroscopicguidance(notshown).
Ourapproachtorepeatthetransrectal,antegradeproced-
ure of Jarow et al. [18], [19] demonstrates, that the pro-
cedure may, although possible, not be quite straightfor-
ward.
To avoid a coiling of the catheter within the lumen of the
rectum, followers should use a microcatheter which fits
into the lumen of the hollow needle used for puncture of
the seminal vesicles such that not only the guidewire but
both,guidewireandcatheterareinsertedintotheseminal
vesicle via the needle.
A device to guide the catheter and guidewire in a curved
angle of approximately 150° within the lumen of the
rectumsuchthattheguidewireandcatheteralreadyenter
the seminal vesicle in the correct direction of the ejacu-
latory ducts would be of great benefit. The same device
oracurvedworkingchannelofaTRUSprobeshouldalso
circumvent the coiling of the catheter within the lumen
of the rectum and enable better transmission of force to
insert the guidewire and catheter into the infundibulum
of the seminal vesicle and to overcome obstructions of
the ejaculatory ducts.
Transgluteal access provides some advantage over
transrectal/endorectalaccess:1.Lowerriskofurogenital
infectionand/orfistulasbetweentherectumandseminal
vesiclescausedbyintestinalbacteria.2.Theinstruments
could be inserted almost straightforward into the ejacu-
latory ducts, it is not necessary to overcome an angle of
approx. 150° as with the transrectal access. 3. Better
guidance by the catheter-sheath and surrounding
pararectal tissue, thus a better transmission of force to
overcome ejaculatory duct obstructions.
Becausetheneedlesareinsertedthroughthethegluteal
and ischiorectal space fat (Figure 4), the risk of bleeding
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Kayser et al.: Less invasive causal treatment of ejaculatory duct ...Figure 4: Anatomical preparation of the transcutaneous course of puncture to the seminal vesicles used for the CT- or MR-
guidedballoondilationoftheejaculatoryducts.UB(urinarybladder),SN(sciaticnerve),U(ureter),VD(vasdeferens),SV(seminal
vesicle), R (rectum), LAM (levator ani muscle), STL (sacrotuberal ligament), PN (pudendal nerve), IAF (ischioanal fossa), EAS
(external anal sphincter).
is minimized. In theory, the periprostatic venous- and
nerve plexus [21] as well as branches of the internal
pudendal artery and the inferior rectal artery within the
periprostaticandpararectalfatcouldbeinjured.However,
130patientswhoreceivedevenmultipleneedlesthrough
the posterior ischiorectal space for brachytherapy of
prostatecancerhadnocomplicationsduetohemorrhage
[22].
Itwaspreviouslydemonstratedthattransgluteal,transis-
chiorectal CT-guided puncture of the seminal vesicles is
feasible for brachytherapy of prostate cancer. None of
37patientshadcomplicationsaccreditedtotheinterven-
tional procedure [23].
Prior to treatment, the percuteaneous intervention could
be supplemented by diagnostic measures such as sem-
inal vesicle aspiration for microscopy [13], injection of
contrast-agent to refute patency and manometry [14].
Althoughitwasnoefforttoplaceaguidewireandcatheter
withintheseminalvesicleviaatranscutaneous,transglu-
teal pathway, we did not manage to advance the
guidewire further into the ejaculatory ducts due to a lack
of realtime imaging resources for better visual guidance
for steering of the guidewire and catheter.
Intheory,onecouldapplyCT-flouroscopyforthispurpose,
however, since the gonadal region of relatively young
patients would be exposed to a relatively high radiation
dose, this kind of realtime visual guidance would be in-
appropriate for the purpose of assisted reproduction.
The most promising imaging modality to guide balloon
dilation of the ejaculatory ducts is magnetic resonance
imaging, since it is already used to guide transrectal and
transgluteal biopsies of the prostate [24], [25] and does
not entail ionizing radiation.
Anothersuitablemodalityforimage-guidedinterventions
is C-arm-CT [26], [27], which provides a combination of
CT (for puncture) and conventional fluoroscopy (for real-
time visual guidance of the catheter and guide-wire).
Thus, relocation of the patient from the CT-Scanner into
the angiographic theatre would be unessential.
AfterCT-guidedplacementofaguide-wireintotheseminal
vesicles, the procedure might even be completed with
image guidance by transabdominal ultrasound or TRUS.
Conclusions
Less-invasive,causaltreatmentofEDObyballoondilation
shouldbefurtherevaluatedinaninterdisciplinaryfashion
by both, urologists and radiologists. Although this case
report describes a partially unsuccessful treatment, we
wereabletodiagnosethepatencyoftheejaculatoryducts
by a minimally invasive, well tolerated procedure. We are
further enrolling patients in the setting of a clinical study
to investigate the outcome and success-rate of trans-
rectal, antegrade recanalisation of the ejaculatory ducts
and to verify the feasibility of the previously-published
procedure.
Percutaneous, transgluteal, transischiorectal, image-
guided ejaculatory ductoplasty (PTED) may be another
promisingnew,less-invasive,causaltreatment-optionfor
EDO.ModernrealtimeimagingressourcessuchasC-arm-
CT or MRI for better guidance of the guide wire and
catheter should be conducive to this intervention and we
encourage hospitals and research groups, which are ac-
cordingly equipped, to contribute to the field.
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